25 Jan 2017 09:02
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1 | Issuer | Oxford BioMedica PLC |
2 | Reason for notification | Notification relates to DTR 3.1.2R |
3 | Name of PDMR | Martin Diggle |
4 | Connected person | Notification relates to following connected persons: Vulpes Life Sciences Fund |
5 | Notification in respect of | Notification in respect of holdings of persons in 4 above |
6 | Description of shares | Oxford BioMedica PLC ordinary shares of 1p each |
7 | Name of registered shareholders and number of shares | Vulpes Life Sciences Fund - 549,732,000 shares Vulpes Testudo Fund - 33,333,333 shares
|
8 | Nature of transaction | Acquisition |
9 | Number of shares acquired
| Vulpes Life Sciences Fund - 200,000 shares
|
10 | Percentage of issued class acquired | Vulpes Life Sciences Fund - 0.01%
|
11 | Shares disposed | N/A
|
12 | Percentage of issued class disposed | N/A
|
13/14 | Price per share of transactions, and date | Vulpes Life Sciences Fund 200,000 shares @ £0.042 , 24 Jan 2017
|
15 | Total holding following notification and total percentage holding following notification | Vulpes Life Sciences Fund - 549,932,000 shares 17.81% Vulpes Testudo Fund - 33,333,333 shares 1.08% |
16 | Date issuer informed | 25 Jan 2017 |
23 | Any additional information | None |
24 | Contact name and telephone number | T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000 |
Oxford Biomedica (OXB)